Post by ITM Isotope Technologies Munich SE

On June 8, Dr. Klaus Maleck, CFO at ITM, had the opportunity to contribute to this year’s “Biotech Finanzgipfel” hosted by BIO Deutschland e. V., a finance summit for experts from the German biotech industry.  Klaus shared insights about ITM’s path from an early pioneer in the radiopharmaceutical field to a global driver, shaped by long-term commitment to innovation in the field, reliable isotope supply, and the continued build-out of capabilities needed to operate at scale. He also highlighted an important aspect of ITM’s evolution: the role of finance in enabling growth, supporting organizational readiness, and helping companies navigate increasing complexity in a highly specialized and regulated environment. Thank you to BIO Deutschland e. V. and all participants for the opportunity to contribute to this year’s summit. #Biotech #Radiopharmaceuticals #Finance